Lattice Biologics Ltd. (OTCPK: LBLT.F)
Health Care · Biotechnology · US
$—
— today · — 1Y
Lattice Biologics Ltd. (OTCPK: LBLT.F) operates in the Biotechnology industry within the Health Care sector. The company is valued at $128.00.
trading between 0.00 and 0.00.
Tweenvest scores Lattice Biologics Ltd. across four factors: quality 29/100, value 49/100, growth 0/100. Its strongest factor is value.
LBLT.F price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $128.00
- Revenue (TTM)
- $1.56M
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- 1.29
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 128.22M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| CardioGenics Holdings IncOTCPK: CGNH | $143.00 | $— | — |
| NexImmune, Inc.OTCPK: NEXI | $139.00 | $— | — |
| PsyBio Therapeutics Corp.OTCPK: PSYB.F | $133.00 | $— | — |
| Marizyme, Inc.OTCPK: MRZM | $132.00 | $— | — |
| Infinity Pharmaceuticals, Inc.OTCPK: INFI.Q | $91.00 | $0.00 | -99.00% |
| RenovaCare, Inc.OTCPK: RCAR | $87.00 | $0.00 | — |
| Statera Biopharma, Inc.OTCPK: STAB | $73.00 | $0.00 | -99.00% |
| Gelesis Holdings, Inc.OTCPK: GLSH.Q | $73.00 | $0.00 | — |
Figures last refreshed Oct 4, 2026.